- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04308876
Effectiveness of Manual Therapy and Strengthening Exercises in Hemophilic Arthropathy of the Elbow Joint
March 12, 2020 updated by: Ayse Merve Tat, Necmettin Erbakan University
Investigation of Effectiveness of Manual Therapy and Strengthening Exercises in Physiotherapy and Rehabilitation of Hemophilic Arthropathy of the Elbow
Manual treatment involves techniques based on the principles of moving the joint faces and separating the joint gap, and soft tissues mobilization techniques.
The use of manual therapy in hemophilia is gradually increasing although it previously described as a contraindication.
The utility and use of strengthening exercises in hemophilia has been going on for a long time.
In this study, the effect of manual therapy and strengthening exercises joint was investigated in hemophilic arthropathy of the elbow.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The aim of this study was to investigate the effects of strengthening exercises and manual therapy on bleeding frequency, pain, range of motion, muscle strength, arm circumference, joint health, functionality and quality of life in the physiotherapy and rehabilitation of hemophilic arthropathy of the elbow.
Seventeen adolescent and young adult hemophilic individuals aged 12-30 years with elbow arthropathy were included in the study.
The individuals were divided into the two groups via simple randomisation as Manuel Therapy and Exercise Group (MTEG) and Home Exercise Group (HEG).
The individuals in HEG were given strengthening exercises as a home program.
Those in the MTEG were applied manual therapy by the physiotherapist and were given supervised strengthening exercises.
All treatments were performed 3 times a week for 5 weeks totally 15 sessions.
Frequency of bleeding was evaluated with number of bleeding in the last 5 weeks.
Numerical Pain Scale was used for activity and resting pain.
Range of motion and muscle strength were measured with universal goniometer and digital dynamometer, respectively.
The Quick-DASH questionnaire and Oxford Elbow Score were used for the functionality of the upper extremity and quality of life, respectively.
The joint health status was evaluated with Hemophilia Joint Health Score-Elbow Point and Hospital for Special Surgery-Elbow Scoring System.
Evaluations were made by the same physiotherapist before and after treatment.
Study Type
Interventional
Enrollment (Actual)
17
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Sarıcam
-
Adana, Sarıcam, Turkey
- Çukurova University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
12 years to 35 years (ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Having signs of hemophilic arthropathy in one or both elbow joints, Being between the ages of 12-30 (Adolescent and young adult), Receiving prophylactic factor replacement therapy.
Exclusion Criteria:
- Having undergone any surgical procedure for elbow arthropathy, Having an orthopedic problem, such as a fracture, ligament or tendon injury, related to the upper limb in the past year, Receiving physiotherapy and rehabilitation for the elbow joint in the last 6 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Manual therapy and strengthening exercises
Manual therapy and strengthening exercises were applied totally 15 sessions for 5 weeks 3 times a week in hospital by physiotherapist.
|
Manual therapy includes techniques applied to elbow joints and surrounding tissues
Strengthening exercises used in this study includes resistant exercises to increase muscle strength of upper extremity
|
|
ACTIVE_COMPARATOR: Strengthening exercises
Patients in this group performed the strengthening exercises given to the experimental group on their own at home with experimental group at the same time, frequency and dose.
|
Strengthening exercises used in this study includes resistant exercises to increase muscle strength of upper extremity
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hemophilia Joint Health Score
Time Frame: 5 week
|
We used the elbow point of Joint Health Status.
Elbow Point is scored 0-20.
A high score indicates that arthropathy findings worsen
|
5 week
|
|
Frequency of bleeding
Time Frame: 5 week
|
It was evaluated wit bleeding number in elbow joint over last 5 week
|
5 week
|
|
Numerical Pain Scale
Time Frame: 5 week
|
It was used for evaluation of activity and resting pain.
|
5 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Range of motion
Time Frame: 5 week
|
It was measured with universal goniometer.
|
5 week
|
|
Muscle strength
Time Frame: 5 week
|
It was measured with digital dynamometer (Lafayette hand-held dynamometer)
|
5 week
|
|
Functionality of the upper extremity
Time Frame: 5 week
|
Quick-Disability of Arm, Shoulder and Hand questionnaire was used.
|
5 week
|
|
Oxford Elbow Score
Time Frame: 5 week
|
It was used for evaluation of Quality of life.
|
5 week
|
|
Physical status of the elbow
Time Frame: 5 week
|
Hospital for Special Surgery-Elbow Scoring System was used.
|
5 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Filiz Can, Professor, Hacettepe University, Faculty of Physical Therapy
- Study Director: Ilgen Sasmaz, Cukurova University, Faculty of Medicine, Department of Pediatric Hematology
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
April 9, 2018
Primary Completion (ACTUAL)
March 10, 2019
Study Completion (ACTUAL)
February 6, 2020
Study Registration Dates
First Submitted
March 12, 2020
First Submitted That Met QC Criteria
March 12, 2020
First Posted (ACTUAL)
March 16, 2020
Study Record Updates
Last Update Posted (ACTUAL)
March 16, 2020
Last Update Submitted That Met QC Criteria
March 12, 2020
Last Verified
March 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Necmettin Erb. Physiotherapy-1
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hemophilia
-
Nantes University HospitalCompletedArthropathy | Moderate HemophiliaFrance
-
ApcinteX LtdCentessa Pharmaceuticals plcTerminatedHemophilia B | Hemophilia a | Hemophilia a with Inhibitor | Hemophilia B with InhibitorGeorgia, Moldova, Republic of
-
Catalyst BiosciencesCompletedHemophilia A | Hemophilia B | Hemophilia A With Inhibitor | Hemophilia B With Inhibitor | Hemophilia A Without Inhibitor | Hemophilia B Without InhibitorBulgaria, Russian Federation
-
BayerCompletedHemophilia A; Hemophilia BIsrael
-
GWT-TUD GmbHHannover Medical School; Hoffmann-La RocheCompleted
-
Laboratoire français de Fractionnement et de BiotechnologiesLFB USA, Inc.CompletedA Phase III Study on the Safety, Pharmacokinetics and Efficacy of Coagulation Factor VIIa (PERSEPT2)Hemophilia A With Inhibitors | Hemophilia B With InhibitorsBulgaria, Ukraine, Czechia, United States, Georgia, South Africa
-
PfizerCompletedFactor VIII Deficiency, Congenital | Hemophilia A, Congenital | Factor 8 Deficiency, Congenital | Autosomal Hemophilia A | Classic Hemophilia
-
Catalyst BiosciencesCompletedHemophilia A With Inhibitor | Hemophilia B With InhibitorArmenia, Georgia, South Africa, Poland, Russian Federation
-
CSL BehringTerminatedHemophilia A With Inhibitors | Hemophilia B With InhibitorsGeorgia, Italy, Malaysia, Russian Federation, South Africa, Spain, Thailand, Ukraine, United Kingdom
-
University College, LondonRecruiting
Clinical Trials on Manual therapy
-
Universidad de ZaragozaCompletedPlagiocephaly | Plagiocephaly, Nonsynostotic | Plagiocephaly, PositionalSpain
-
Investigación en Hemofilia y FisioterapiaCompleted
-
Josue Fernandez CarneroUniversidad Autonoma de MadridCompletedCervicalgia | Neck Pains | Posterior Cervical Pains | Posterior Neck Pain
-
Alexander AchalandabasoCompletedChronic Pain | Neck PainSpain
-
Hacettepe UniversityCompletedHealth Young IndividualsTurkey
-
Universidad de ZaragozaCompletedEndodontically Treated Teeth | Root Canal TherapySpain
-
Imam Abdulrahman Bin Faisal UniversityUnknownLow Back Pain, MechanicalSaudi Arabia
-
Cesar A Hincapié, DC PhDEpidemiology, Biostatistics and Prevention Institute, University of ZurichCompletedBack Pain | Back Pain, Low | Back DisorderSwitzerland
-
University of PalermoCompleted